Global CRO footprint IHC operates as a full service CRO with global staff and regional monitors across the United States, Europe, Latin America and Canada, presenting a scalable, worldwide reach for multinational clinical programs.

Full service capabilities Offering design, monitoring, management of all clinical trial phases plus regulatory services suggests cross-sell opportunities to pharma, biotech, and medical device clients seeking end-to-end development and submission support.

Technology leverage Emphasis on sophisticated, state-of-the-art technology for data integrity and accelerated research; potential to position IHC to clients seeking modern, compliant data platforms and streamlined trial operations.

Mid-market footprint With 11-50 employees and revenue in the 1–10 million range, IHC sits in the small to mid-size CRO segment, presenting an opportunity to win larger programs through partnerships or tiered service offerings while expanding capacity.

Awards & credibility Recognition such as the Risk Management Provider of the Year Award enhances credibility with risk-based monitoring and quality-focused buyers, supporting pitch material for bidding and competitive differentiation.